Inventor · disambiguated record
Hiromi Yoshida
Also filed as: YOSHIDA HIROMI
5 granted patents·7 pending applications·26 citations·filing 1985–2023
74Inventor score
Files withTAKEDA PHARMACEUTICAL5UNIV KAGAWA NAT UNIV CORP3ITOH FUMIO2NIPPON KAYAKU KK1TAKEDA PHARMACEUTICALS CO1
Top patents by PatentIndex Score
12 records- 0188US7217808B2RFRP-3 and DNA thereofTAKEDA PHARMACEUTICAL·Filed 2005·Granted May 15, 2007·5 cites·6 claims
- 0282US4659722ABactericidal N-(2,2,2 trichloroethyl)pyridinecarboxamidesNIPPON KAYAKU KK·Filed 1985·Granted Apr 21, 1987·19 cites·11 claims
- 0373US7041789B2RFRP-3 and DNA thereofTAKEDA PHARMACEUTICAL·Filed 2002·Granted May 9, 2006·2 cites·3 claims
- 0461US2025188439A1Dried body of immobilized enzyme which is an enzyme capable of enduring drying, and manufacturing method and preservation method thereforeUNIV KAGAWA NAT UNIV CORP·Filed 2023·Application pending·0 cites
- 0558US7943137B2FPRL1 ligands and use thereofTAKEDA PHARMACEUTICAL·Filed 2003·Granted May 17, 2011·0 cites·26 claims
- 0658US2009239839A1Receptor antagonistTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 0756US2024002828A1Novel l-rhamnose isomeraseUNIV KAGAWA NAT UNIV CORP·Filed 2021·Application pending·0 cites
- 0848US7268212B2Ligand of G protein-coupled receptor protein and DNA thereofTAKEDA PHARMACEUTICAL·Filed 2002·Granted Sep 11, 2007·0 cites·6 claims
- 0948US2007117840A1Receptor antagonistITOH FUMIO·Filed 2004·Application pending·0 cites
- 1047US2021395718A1Novel ketose 3-epimeraseUNIV KAGAWA NAT UNIV CORP·Filed 2019·Application pending·0 cites
- 1146US2007129348A1Receptor antagonistITOH FUMIO·Filed 2004·Application pending·0 cites
- 1239US2019338251A1Skeletal Muscle Precursor Cells and Production Method for Skeletal Muscle CellsTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hiromi Yoshida files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →